This 2025 study aims to understand the utility of QbCheck in a remote setting and to test its effectiveness in monitoring treatment outcomes and symptom progression over time.
Conducted with the ADHD 360 care model in the UK, the study found statistically significant improvements across all objective QbCheck measures following treatment. with Total Symptom Score (TSS) improving by 46.28% (p < 0.001). These objective changes showed moderate but significant correlations with subjective rating scales, including the QbCheck Rating Scale (r = 0.38) and ASRS/SNAP (r = 0.34). Researchers observed strong correlations between subjective measures at baseline and follow-up (p < 0.001).
The findings also highlight variability in individual treatment response, emphasizing the need for personalized approaches to ADHD management.
ADHD 360 is a UK-based virtual healthcare service specializing in Attention-Deficit/Hyperactivity Disorder (ADHD) diagnosis and treatment. ADHD 360 sought to address ongoing challenges in maintaining accessibility, consistency, and quality of care; areas that are increasingly scrutinized in ADHD service delivery models worldwide.
They incorporated QbCheck, a standardized, objective, and remote ADHD assessment tool, into their clinical workflow. The integration aimed to reduce reliance on subjective symptom reporting, enhance diagnostic accuracy, and optimize clinician time without compromising assessment quality.
Ragini Sanyal, Núria Casals, Simon Larsson, Natalie Jennings,
Alex Lloyd, Phil Anderton, Mikkel Hansen
